Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
Ikura
Yoshihiro
Y
Iwasa
Yoko
Y
Ueda
Makiko
M
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D055166:Hepatic Stellate Cells / Q000187:drug effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D014635:Valproic Acid